Vonita Chawla
Sourced from institutional research profiles (UAMS TRI or ARA).
Assistant Professor (Neonatology)
Also affiliated: Arkansas Children's Hospital (2024–2026)
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Vonita Chawla's research focuses on advancements in neonatal care, particularly neuroprognostication for conditions like neonatal encephalopathy. Her work investigates the application of artificial intelligence (AI) in this field, aiming to improve diagnostic and prognostic capabilities. She also studies the outcomes and management of extremely premature neonates, including those born at 22 weeks of gestation, and explores treatment strategies for specific neonatal conditions such as non-immune hydrops in preterm infants and necrotizing enterocolitis. Chawla's publications also address practice variations in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease and provide commentary on current clinical trials and practices in neonatology. Her research contributes to understanding brain development and injury in newborns and the potential of emerging technologies in neonatal medicine.
Metrics
- h-index: 2
- Publications: 6
- Citations: 8
Positions
-
Assistant Professor (Neonatology) 2022–presentUniversity of Arkansas Medical Center Pediatrics ORCID
-
Assistant Professor (Neonatology) 2022–presentArkansas Children's Hospital Pediatrics ORCID
-
Assistant Professor (Neonatology) publications 2022–2026University of Arkansas for Medical Sciences Institutional directory
Selected Publications
-
Emerging modalities for neuroprognostication in neonatal encephalopathy: harnessing the potential of artificial intelligence (2025)
-
Brainstem microglial cell morphology in neonatal rats with necrotizing enterocolitis and the effects of prenatal heparin-binding epidermal growth factor-like growth factor (2025)
-
Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States (2024)
-
EBNEO Commentary: Management and outcomes of periviable neonates born at 22 weeks of gestation: A single‐center experience in Japan (2024)
-
EBNEO commentary on “umbilical cord milking in nonvigorous infants: A cluster‐randomised crossover trial” (2022)
Collaboration Network
Top Collaborators
- Emerging modalities for neuroprognostication in neonatal encephalopathy: harnessing the potential of artificial intelligence
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
- Practice variation in therapeutic hypothermia for hypoxic ischemic encephalopathy among neonates with congenital heart disease in the United States
Similar Researchers
Based on overlapping research topics